Transcriptional Regulation of the Colorectal Cancer Stem Cell Markers, Nanog and Oct4, Induced by a Thermodynamic-Based Therapy Approach
- PMID: 37551178
- PMCID: PMC10404326
- DOI: 10.18502/ijph.v52i4.12458
Transcriptional Regulation of the Colorectal Cancer Stem Cell Markers, Nanog and Oct4, Induced by a Thermodynamic-Based Therapy Approach
Abstract
Background: Cancer stem cells (CSC), as responsible issues to cancer development and progression, play a crucial role in tumorigenesis, recurrence, metastasis, and chemoresistance. Both hyperthermia and photodynamic therapy (PDT) may be effective for cancer treatment, particularly when combined with other therapeutic approaches. This study aimed to evaluate the effect of hyperthermia combined with PDT on colorectal CSC and the gene expression of the CSC markers, presenting a more effective approach for cancer therapy.
Methods: The study was conducted in the Pasteur institute of Iran, Tehran, Iran in 2018. We evaluated the anticancer role of hyperthermia, Gold nanoparticles coated with curcumin (Cur-GNPs) in PDT and combination of the two approaches on cell viability and the expression of CSC markers, Nanog and Oct4 in colorectal cancer cell line HT-29. The cytotoxicity effect of Cur-GNPs against the cells was assessed in vitro. The cell viability was assessed using MTT assay, and the expression analysis of the CSC genes was evaluated using a q-real-time PCR.
Results: Cell viability was decreased by PDT (P=0.015) and the combination therapy (P=0.006) but not by hyperthermia alone (P=0.4), compared to control. Also, the expression of CSC markers, Nanog and Oct4 was shown to significantly down-regulate in all hyperthermia, PDT and combination groups.
Conclusion: Hyperthermia combined with PDT was indicated to be more efficient in eliminating tumors than hyperthermia or PDT alone.
Keywords: Colorectal cancer stem cell; Hyperthermia; Nanog; Photodynamic therapy.
Copyright © 2023 Ghorbani et al. Published by Tehran University of Medical Sciences.
Conflict of interest statement
Conflict of interest Authors declare no conflict of interests.
Figures



Similar articles
-
Gene Expression Patterns of Colorectal Cancer Stem Cells Following Ibuprofen and Hyperthermia Treatment.Iran J Public Health. 2024 Mar;53(3):726-736. doi: 10.18502/ijph.v53i3.15155. Iran J Public Health. 2024. PMID: 38919292 Free PMC article.
-
[LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].Zhonghua Bing Li Xue Za Zhi. 2018 Apr 8;47(4):284-290. doi: 10.3760/cma.j.issn.0529-5807.2018.04.011. Zhonghua Bing Li Xue Za Zhi. 2018. PMID: 29690669 Chinese.
-
Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.J Hematol Oncol. 2015 Mar 11;8:23. doi: 10.1186/s13045-015-0119-3. J Hematol Oncol. 2015. PMID: 25879771 Free PMC article.
-
Role of cancer stem cells in head-and-neck squamous cell carcinoma - A systematic review.J Carcinog. 2021 Sep 23;20:12. doi: 10.4103/jcar.JCar_14_20. eCollection 2021. J Carcinog. 2021. PMID: 34729044 Free PMC article. Review.
-
Resistance to Cell Death and Its Modulation in Cancer Stem Cells.Crit Rev Oncog. 2016;21(3-4):203-219. doi: 10.1615/CritRevOncog.2016016976. Crit Rev Oncog. 2016. PMID: 27915972 Free PMC article. Review.
References
-
- Akbari A, Mobini GR, Maghsoudi R, et al. ( 2016). Modulation of transforming growth factor-β signaling transducers in colon adenocarcinoma cells induced by staphylococcal enterotoxin B. Mol Med Rep, 13( 1): 909–914. - PubMed
-
- Emami SS, Akbari A, Zare A-A, et al. ( 2019). MicroRNA expression levels and histopathological features of colorectal cancer. J Gastrointest Cancer, 50( 2): 276–284. - PubMed
-
- Takimoto R, Kamigaki T, Okada S, et al. ( 2019). Prognostic factors for colorectal cancer patients treated with combination of immune-cell therapy and first-line chemotherapy: A retrospective study. Anticancer Res, 39( 8): 4525–4532. - PubMed
-
- Kim J-E, Shin J-Y, Cho M-H. ( 2012). Magnetic nanoparticles: an update of application for drug delivery and possible toxic effects. Arch Toxicol, 86( 5): 685–700. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials